National HealthCare 3Q 2026: Revenue $407.97M, EPS $0.85 — 10-Q Summary
National HealthCare reported 3Q 2026 revenue of $407.97M, up 6.6% YoY, but net income fell 65.2% to $13.64M. EPS declined 66% to $0.85. Growth was driven by higher skilled-nursing rates and acquisitions, while unrealized losses on securities impacted earnings. The company's average skilled-nursing census was 90.4%, with 51 facilities rated four or five stars.
How this was made
The 30-second read
Why it matters
The earnings miss may trigger short‑term sell pressure, but the acquisition activity could be a catalyst for longer‑term upside.
Market read
First‑time disclosure of quarterly results provides fresh data for traders to reassess valuation.
What to watch
Higher per‑diem rates and improved quality ratings may support future revenue growth.
Background
The article summarizes National HealthCare's Form 10‑Q filing for Q3 2026, highlighting revenue growth, earnings decline, and recent facility acquisitions.
Ticker impact
National HealthCare reported Q3 2026 revenue of $408M and EPS $0.85, with net income falling 65% YoY.
likely downward pressure as investors price in weaker earnings and higher unrealized losses
Revenue grew modestly while net income collapsed, indicating margin compression and potential cash flow concerns.
Market effects
Skilled‑nursing sector may see broader scrutiny as earnings pressure highlights operational challenges.
U.S. healthcare investors could adjust exposure to senior‑care operators.
Limited; primarily affects U.S. listed health‑care stocks.
Counterpoint
If the acquisition pipeline accelerates, the stock could rebound despite short‑term earnings weakness.
Key entities
- companyNational HealthCare Corp
U.S. senior‑care operator reporting Q3 2026 results.
